Aflibercept monotherapy or bevacizumab first for diabetic macular edema
Purpose: Clinical outcome and switch patterns with bevacizumab first treatment strategy for patients with newly diagnosed neovascular age-related macular degeneration (nAMD). Methods: Retrospective observational study of the number of intravitreal injections of bevacizumab and treatment switch in pa...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Серія: | Indian Journal of Ophthalmology |
| Предмети: | |
| Онлайн доступ: | http://www.ijo.in/article.asp?issn=0301-4738;year=2024;volume=72;issue=14;spage=260;epage=264;aulast=Hostovsky |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|